First-line sequential high-dose VIP chemotherapy with autologous transplantation for patients with primary mediastinal nonseminomatous germ cell tumours: a prospective trial

To determine the efficacy of first-line sequential high-dose VIP chemotherapy (HD-VIP) in patients with primary mediastinal nonseminomatous germ cell tumours (GCT), 28 patients were enrolled on a German multicentre trial. High-Dose VIP chemotherapy consisted of 3–4 cycles of dose-intensive etoposide...

Descripción completa

Detalles Bibliográficos
Autores principales: Bokemeyer, C, Schleucher, N, Metzner, B, Thomas, M, Rick, O, Schmoll, H-J, Kollmannsberger, C, Boehlke, I, Kanz, L, Hartmann, J T
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2003
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394224/
https://www.ncbi.nlm.nih.gov/pubmed/12838296
http://dx.doi.org/10.1038/sj.bjc.6600999

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394224/
https://www.ncbi.nlm.nih.gov/pubmed/12838296
http://dx.doi.org/10.1038/sj.bjc.6600999

Ejemplares similares